LAVOLPE, Vito Grazio
 Distribuzione geografica
Continente #
NA - Nord America 2.273
AS - Asia 737
EU - Europa 551
SA - Sud America 156
AF - Africa 45
OC - Oceania 5
Totale 3.767
Nazione #
US - Stati Uniti d'America 2.260
SG - Singapore 287
CN - Cina 209
BR - Brasile 138
SE - Svezia 108
RU - Federazione Russa 93
HK - Hong Kong 92
VN - Vietnam 83
DE - Germania 74
IT - Italia 66
UA - Ucraina 57
GB - Regno Unito 47
FI - Finlandia 36
CI - Costa d'Avorio 35
BE - Belgio 20
IN - India 16
FR - Francia 12
AR - Argentina 8
BD - Bangladesh 7
CA - Canada 7
JP - Giappone 7
NL - Olanda 7
LT - Lituania 6
SK - Slovacchia (Repubblica Slovacca) 6
ZA - Sudafrica 6
TR - Turchia 5
AU - Australia 4
ID - Indonesia 4
KR - Corea 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
ES - Italia 3
IE - Irlanda 3
IL - Israele 3
IQ - Iraq 3
IR - Iran 3
MX - Messico 3
PE - Perù 3
PL - Polonia 3
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
MY - Malesia 2
PT - Portogallo 2
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
JO - Giordania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.767
Città #
Dallas 740
Singapore 157
Chandler 152
Ashburn 150
Fairfield 134
Jacksonville 133
Woodbridge 124
Beijing 91
Houston 90
Hong Kong 89
Ann Arbor 83
Nyköping 78
Seattle 53
Wilmington 47
Cambridge 42
Abidjan 35
Bari 32
Los Angeles 31
Dong Ket 28
Nanjing 26
Lawrence 25
Roxbury 25
Brooklyn 21
Ho Chi Minh City 21
North Bergen 20
Des Moines 19
Kansas City 19
New York 19
Brussels 18
Munich 18
Boardman 16
Hanoi 12
Jiaxing 12
Buffalo 11
Hebei 11
Princeton 10
Grottaglie 9
London 8
San Diego 8
São Paulo 8
Tokyo 7
Inglewood 6
Santa Clara 6
Shenyang 6
Franca 5
Helsinki 5
Rio de Janeiro 5
Shanghai 5
Amsterdam 4
Belo Horizonte 4
Brasília 4
Johannesburg 4
Nanchang 4
Ningbo 4
Nuremberg 4
Pune 4
Redwood City 4
Toronto 4
West Jordan 4
Zhengzhou 4
Ankara 3
Auburn Hills 3
Boston 3
Bratislava 3
Brescia 3
Changsha 3
Curitiba 3
Dearborn 3
Grafing 3
Moscow 3
Orem 3
Palermo 3
Paris 3
Phoenix 3
San Francisco 3
São José dos Campos 3
Taichung 3
Taizhou 3
The Dalles 3
Tianjin 3
Turku 3
Warsaw 3
Baku 2
Bogotá 2
Brno 2
Buon Ma Thuot 2
Can Tho 2
Canoas 2
Charlotte 2
Chennai 2
Chicago 2
Columbus 2
Da Nang 2
Dhaka 2
Dublin 2
Gangnam-gu 2
Garanhuns 2
Honolulu 2
Hyderabad 2
Ijuí 2
Totale 2.820
Nome #
1 - 10 of 10 One page. 1: Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia 965
A case of unilateral burning mouth syndrome of neuropathic origin 161
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 146
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features 133
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 130
Effects of preservation solutions on blood 124
A Case of Unilateral Burning Mouth Syndrome of Neuropathic Origin 119
Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies 117
C'era una volta la Didattica...e adesso? 114
Neutralizing and binding antibodies to interferon beta in patients with multiple sclerosis: a comparison of assay results from three italian centres 112
A population-based surveillance Italian study of Interferon beta treatment in Multiple Sclerosis patients: relationships between neutralizing antibodies production and clinical outcomes 110
null 109
A case of vacuolar myopathy during the course of chronic hepatitis C 108
Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia 97
Correlations between neutralizing antibodies production and clinical outcomes: analysis in a population-based surveillance italian study of interferon beta treatment in multiple sclerosis patients 91
CORRELATIONS BETWEEN NEUTRALIZING ANTIBODIES PRODUCTION AND CLINICAL OUTCOMES: ANALYSIS IN A POPULATION- BASED SURVEILLANCE ITALIAN STUDY OF INTERFERON BETA TREATMENT IN MULTIPLE SCLEROSIS PATIENTS 88
Anti-neuronal glycolitic enzymes antibodies: a study on primary neuronal striatal cultures 86
L'open access e l'Università. Il modello proposto dalla Facoltà di Medicina e Chirurgia di Bari 83
Neutralizing antibodies during treatment of relapsing Multiple Sclerosis patients with three interferon beta: correlation with clinical outcomes 79
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 78
Post-Thromboembolic pulmonary hypertension: a complex case 76
Left ventricular dysfunction in cardiac metastatic melanoma: nivolumab induced immunotoxicity or direct myocardial damage? 76
Pulmonary arterial hypertension and hiv infection 74
Vasovagal syncope and covid-19 72
Interferon-b treatment in relapsing remitting multiple sclerosis: results of an observational study in southern Italy 72
Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients 68
Università e modelli di web-leasrning 66
Interferon-b treatment in relapsing remitting multiple sclerosis: results of an observational study in southern Italy 65
L’ATROFIA MUSCOLARE SPERIMENTALE DEL GINOCCHIO DOPO IMMOBILIZZAZIONE E LESIONE LEGAMENTOSA DEL GINOCCHIO 64
Wath's behind pericardial effusion? A difficult differential diagnosis 61
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study. 51
Totale 3.795
Categoria #
all - tutte 12.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 5 25 12 30 38 12 43
2021/2022191 11 23 1 11 5 10 7 10 7 23 39 44
2022/2023408 57 61 23 33 64 43 3 45 67 3 5 4
2023/2024136 10 27 6 18 9 28 5 3 2 6 8 14
2024/2025583 10 10 50 48 20 33 55 37 66 31 66 157
2025/20261.409 197 213 683 108 143 65 0 0 0 0 0 0
Totale 3.795